VirHealth

VirHealth is pleased to announce the implementation of new trial procedures aimed at evaluating the efficacy of surface disinfectants, whether used with or without mechanical action (wipes), as well as surface disinfection systems through airborne methods, against Adeno-Associated-Virus (AAV) vectors used in gene therapy. VirHealth has developed a new test bench to meet the requirements of EN17272 (2020, airborne disinfection system) for small-enclosure efficacy tests of 2 m3. We are pleased to announce the publication of the study "Antiviral Activity of Active Materials: Standard and Finger-Pad-Based Innovative Experimental Approaches" in the international review Materials. NeoVirTech and VirHealth join their virology expertise to provide customers one of the most extended virus disinfection measurement and R&D platform in France and in Europe. It relates to our project on the Performance and Durability of Antimicrobial Products. We offer standardized or adapted protocols to evaluate the antiviral efficacy of porous and non-porous surfaces on a large panel of viruses (enveloped and non- enveloped) including alpha/beta coronaviruses.